OTCA15 – Final Assessment and input from external experts and manufacturers are now available
We are pleased to announce that the final assessment for OTCA15 “Irreversible electroporation in liver and pancreatic cancer”, together with the input from external experts and manufacturers, are now available for access.
Irreversible electroporation (IRE) is a nonthermal ablative method based on the application of short high-voltage and low-frequency electric fields to destroy tissue. The purpose of the assessment is to evaluate the relative effectiveness and safety of IRE for locally advanced pancreatic cancer and hepatic cancers that are contraindicated for thermal ablation, in comparison to the standard care.
Please see the following links for access to all relevant assessment documentation:
OTCA15 Final Assessment HERE
Input from external experts and manufacturers HERE
OTCA15 Project Plan HERE
OTCA15 Project Plan External Expert and Manufacturer Comments HERE